Trellus Health (FRA:85Q) Stock Based Compensation: €0.01 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Trellus Health Stock Based Compensation?

Trellus Health FRA:85Q Stock Based Compensation is €0.01 Mil as of Jun. 2025. The stock has 2 warning signs investors should review.

Trellus Health's Stock Based Compensation for the six months ended in Jun. 2025 was €0.01 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2025 was €0.01 Mil.

Trellus Health Stock Based Compensation Related Terms

Trellus Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Trellus Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trellus Health Stock Based Compensation Chart

Trellus Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
0.00 0.12 0.06 0.02 0.01

Trellus Health Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 0.01

Trellus Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.01 Mil.

What does a Stock Based Compensation of €0.01 Mil mean?
Trellus Health (FRA:85Q) has a Stock Based Compensation of €0.01 Mil as of Jun. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Trellus Health and its competitors.
Is Trellus Health's Stock Based Compensation too high?
Trellus Health's current Stock Based Compensation is €0.01 Mil.
How does Trellus Health's Stock Based Compensation compare to VEEV and BTSG?
Trellus Health's Stock Based Compensation of €0.01 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Trellus Health and its competitors. Trellus Health's current Stock Based Compensation is €0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (FRA:85Q) has a current Stock Based Compensation of €0.01 Mil. The current Stock Based Compensation is €0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Trellus Health (FRA:85Q), the current Stock Based Compensation is €0.01 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trellus Health Business Description

Other Exchanges TRLS:UK
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.